Quarterly and Annual Revenue Growth
Q4 (12-week) revenue grew 3.5% to $15.5 billion; full-year consolidated revenue grew 4.4% to $63.7 billion. On a reported basis (including extra week), revenue grew ~11% in the quarter.
Profitability and EPS Expansion
Adjusted EBITDA increased 4.8% to $1.8 billion and adjusted diluted net earnings per share grew 10.9% in the quarter. Full-year EPS grew 10.7% (13.6% including the 53rd week). Reported adjusted EPS in the quarter was $0.67, up 22%.
Retail Margin and EBITDA Improvements
Retail gross margin improved 10 basis points to 31.0%. Retail adjusted EBITDA grew 4.6% and retail EBITDA margin increased 10 basis points to 10.9%.
Same-Store and Absolute Sales Momentum
Food same-store sales grew 1.5%; absolute food sales grew 3.1%, outpacing same-store by 160 basis points due to new store openings. Drug retail absolute sales increased 4.4% with same-store sales up 3.9%.
Hard Discount and New Store Growth
Opened 30 stores in Q4 and 48 Hard Discount (No Frills/Maxi) stores during the year (15 in Q4). Hard Discount stores are meeting expectations; 20 stores opened in 2024 are already in comps and averaging healthy double-digit same-store sales.
Digital & E-commerce Expansion
Online sales exceeded $4.5 billion for the year; digital sales increased 19.6% in Q4 (highest growth in the year). Delivery-led growth (including new third-party delivery partnerships) and improved e-commerce economics (no longer dilutive) were highlighted.
Pharmacy & Healthcare Progress
Pharmacy and health care services same-store sales grew 5.6%, driven by prescription and specialty prescription strength. Target of opening 250 in-store clinics was achieved, expanding access to care.
Capital Allocation and Cash Returns
Retail free cash flow was $1.9 billion for the year. The company repurchased $592 million of common shares in the quarter and $1.9 billion for the full year, and plans to return most free cash flow to shareholders in 2026 (targeting ~ $1.9B buybacks).
Balance Sheet and Returns
Reported return on equity of 26.3% and return on capital of 12.4%; balance sheet described as strong.
Operational Investments Advancing
Automated distribution center (East Gwillimbury) ramped ahead of plan (ambient sections rolled out 2 months early) with cost/productivity improvements; second automated DC (South Caledon) on plan. Planned 2026 CapEx approximately $2.4 billion.
Private Label and Adjacent Business Growth
Introduced >250 new private-label products generating nearly $400 million in sales. Lifemark expanded (320 locations, ~4M visits) and expected to deliver ~$100 million EBITDA this year. Growth in retail media, logistics-as-a-service and healthcare services noted.
Strategic Partnership and Simplification of Financial Services
Announced sale of PC Financial to EQ Bank; PC Financial revenue rose 3.1% and adjusted net earnings increased ~36% (up $12 million). Transaction will convert discontinued ops into a proportional ownership share of EQB profits once closed.
Technology & AI Adoption
Progress on agentic AI and customer-facing integrations (partnerships with OpenAI and Google); internal AI tools (e.g., Robin) being used to improve forecasting, assortment, and store operations—positioned as long-term differentiator.